🇺🇸 FDA
Patent

US 9173975

Reparative cell delivery via hyaluronic acid vehicles

granted A61KA61K35/12A61P

Quick answer

US patent 9173975 (Reparative cell delivery via hyaluronic acid vehicles) held by The Board of Regents of the University of Texas System expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K35/12, A61P, A61P1/00, A61P17/02